Madalina Chirieac

720 total citations · 1 hit paper
12 papers, 504 citations indexed

About

Madalina Chirieac is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, Madalina Chirieac has authored 12 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 3 papers in Neurology and 3 papers in Rheumatology. Recurrent topics in Madalina Chirieac's work include Multiple Sclerosis Research Studies (5 papers), Peripheral Neuropathies and Disorders (3 papers) and Celiac Disease Research and Management (2 papers). Madalina Chirieac is often cited by papers focused on Multiple Sclerosis Research Studies (5 papers), Peripheral Neuropathies and Disorders (3 papers) and Celiac Disease Research and Management (2 papers). Madalina Chirieac collaborates with scholars based in United States, United Kingdom and Germany. Madalina Chirieac's co-authors include David Margolin, Douglas L. Arnold, Alasdair Coles, D. A. S. Compston, Krzysztof Selmaj, Eva Havrdová, Hans‐Peter Hartung, Jeffrey Cohen, Barbara Gracious and Anthony Traboulsee and has published in prestigious journals such as New England Journal of Medicine, Neurology and Journal of the American Society of Nephrology.

In The Last Decade

Madalina Chirieac

12 papers receiving 500 citations

Hit Papers

Inaxaplin for Proteinuric Kidney Disease in Persons with ... 2023 2026 2024 2025 2023 25 50 75
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants
    2023 98 citations Ogo Egbuna, Brandon Zimmerman et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Madalina Chirieac United States 7 277 111 105 90 89 12 504
José M.A. Wijnands Canada 14 418 1.5× 137 1.2× 47 0.4× 39 0.4× 112 1.3× 25 612
David Li United States 11 245 0.9× 146 1.3× 63 0.6× 29 0.3× 10 0.1× 26 480
Caroline Protin France 8 149 0.5× 94 0.8× 52 0.5× 90 1.0× 6 0.1× 19 576
Antonio G. Tristano Venezuela 11 83 0.3× 42 0.4× 25 0.2× 65 0.7× 21 0.2× 25 454
Larisa Dzeranova Russia 13 160 0.6× 38 0.3× 73 0.7× 11 0.1× 66 0.7× 133 585
Claire Dossier France 15 146 0.5× 10 0.1× 73 0.7× 88 1.0× 367 4.1× 42 571
Ahmet Omma Türkiye 14 42 0.2× 32 0.3× 33 0.3× 149 1.7× 39 0.4× 103 608
Tatyana Ionova Russia 10 142 0.5× 25 0.2× 200 1.9× 25 0.3× 10 0.1× 90 469
Katarzyna Kapica-Topczewska Poland 11 158 0.6× 87 0.8× 28 0.3× 35 0.4× 12 0.1× 54 414
Nuria Navarrete‐Navarrete Spain 14 103 0.4× 30 0.3× 25 0.2× 192 2.1× 19 0.2× 32 505

Countries citing papers authored by Madalina Chirieac

Since Specialization
Citations

This map shows the geographic impact of Madalina Chirieac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Madalina Chirieac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Madalina Chirieac more than expected).

Fields of papers citing papers by Madalina Chirieac

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Madalina Chirieac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Madalina Chirieac. The network helps show where Madalina Chirieac may publish in the future.

Co-authorship network of co-authors of Madalina Chirieac

This figure shows the co-authorship network connecting the top 25 collaborators of Madalina Chirieac. A scholar is included among the top collaborators of Madalina Chirieac based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Madalina Chirieac. Madalina Chirieac is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Egbuna, Ogo, Brandon Zimmerman, George Manos, et al.. (2023). Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants. New England Journal of Medicine. 388(11). 969–979. 98 indexed citations breakdown →
2.
Falk, Ronald J., Laura Barisoni, David J. Friedman, et al.. (2022). Design of a Phase 2/3 Adaptive Trial Evaluating Inaxaplin in APOL1-Mediated Kidney Disease. Journal of the American Society of Nephrology. 33(11S). 181–182. 1 indexed citations
3.
Coles, Alasdair, Douglas L. Arnold, Ann Bass, et al.. (2021). Efficacy and safety of alemtuzumab over 6 years: final results of the 4-year CARE-MS extension trial. Therapeutic Advances in Neurological Disorders. 14. 1279203702–1279203702. 34 indexed citations
4.
5.
Wray, Sibyl, Eva Havrdová, David R. Snydman, et al.. (2018). Infection risk with alemtuzumab decreases over time: pooled analysis of 6-year data from the CAMMS223, CARE-MS I, and CARE-MS II studies and the CAMMS03409 extension study. Multiple Sclerosis Journal. 25(12). 1605–1617. 60 indexed citations
6.
7.
8.
Selmaj, Krzysztof, Mario Habek, Ann Bass, et al.. (2017). Efficacy and Safety of Alemtuzumab in Patients With RRMS Is Durable Over 10 Years: Follow-up From the CAMMS223 Study (P5.338). Neurology. 88(16_supplement). 6 indexed citations
9.
10.
Coles, Alasdair, Jeffrey Cohen, Edward Fox, et al.. (2017). Alemtuzumab CARE-MS II 5-year follow-up. Neurology. 89(11). 1117–1126. 212 indexed citations
11.
Gracious, Barbara, et al.. (2010). Prevalence of Overweight and Obesity in Adolescents With Severe Mental Illness. The Journal of Clinical Psychiatry. 71(7). 949–954. 19 indexed citations
12.
Gracious, Barbara, et al.. (2010). Randomized, placebo‐controlled trial of flax oil in pediatric bipolar disorder. Bipolar Disorders. 12(2). 142–154. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by José M.A. Wijnands Breakdown of academic impact, for papers by David Li Breakdown of academic impact, for papers by Caroline Protin Breakdown of academic impact, for papers by Antonio G. Tristano Breakdown of academic impact, for papers by Larisa Dzeranova Breakdown of academic impact, for papers by Claire Dossier Breakdown of academic impact, for papers by Ahmet Omma Breakdown of academic impact, for papers by Tatyana Ionova Breakdown of academic impact, for papers by Katarzyna Kapica-Topczewska Breakdown of academic impact, for papers by Nuria Navarrete‐Navarrete
Rankless by CCL
2026